By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aton Pharma, Inc. (Acquired by Merck & Co., Inc.) 

Press releases archived for reference only.

Tarrytown  New York  10591-6717  U.S.A.
Phone: 914-347-2900 Fax: 914-347-2002


Company News
Valeant Pharmaceuticals International (VRX) Completes Acquisition of Aton Pharma, Inc. 5/27/2010 8:46:32 AM
Aton Pharma, Inc.: Study of Lacrisert(R) Dry Eye Insert 5/3/2010 1:09:41 PM
Valeant Pharmaceuticals International (VRX) to Acquire Aton Pharma, Inc. for About $318 Million 5/3/2010 7:25:23 AM
Bristol-Myers Squibb Company (BMY) Parkinsons's Drug Acquired by Aton Pharma, Inc. 4/26/2010 8:34:29 AM
Aton Pharma, Inc. Launches Authorized Generic Version of Glaucoma Eye Drop Timoptic-XE(R) Gel Forming Solution 3/9/2010 10:51:44 AM
Aton Pharma, Inc. Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations 2/16/2010 9:03:09 AM
Aton Pharma, Inc. Announces Michael H. Richardson to Head Orphan Drug Division 2/9/2010 8:22:33 AM
Aton Pharma, Inc. Study of Lacrisert(R) Dry Eye Insert Published in The Ocular Surface 8/19/2009 8:41:43 AM
Aton Pharma, Inc. Release: Association for Research in Vision & Ophthalmology, AOS: Large Study of Lacrisert(R) Dry Eye Insert; Patients Experience Significant Improvement in Ocular Surface Disease and Quality of Life 5/4/2009 11:13:06 AM
Aton Pharma, Inc. Announces Large Study of Lacrisert(R) Dry Eye Insert 5/4/2009 8:13:57 AM